PCI High Potent Manufacturing
LB Bohle – 10.06.2025
Temax_Krautz

Current Edition

Current Edition

Subsection - CDMO

Examining how innovative technologies, integrated manufacturing approaches and AI are shaping manufacturing.

Continue reading

Subsection - Injectables

Exploring advances in injectable drug delivery and sterile manufacturing, designed to improve patient-centric delivery.

Continue reading

Subsection - Neurodegenerative Diseases

Exploring emerging approaches to neurodegenerative disease research and treatment.

Continue reading

Subsection - Nasal & Pulmonary

Highlighting how advances in nasal and pulmonary drug delivery, formulation, devices and analytics are enabling more complex therapies.

Continue reading

Advertisement

CPHI 2027
DDL 2026

Advertisement

Nipro August 26

Advertisement

Merxin March 2026

Advertisement

Aurisco 300×250

Advertisement

Lifecore Biomedical

Leena Contarino, Partner, joins HGF Basel Office

HGF are pleased to announce further growth of the team in the Basel office with the arrival of Leena Contarino who joined the firm’s Basel office as a Partner on Thursday 1st November 2018.
 
Leena has considerable experience in inventions related to proteins, nucleic acids, diagnostics utilising biomolecules, as well as cells, including microbes.  Her expertise covers preparing and prosecuting patent applications, strategic patent portfolio review and management, intellectual property due diligence, and opinions regarding freedom-to-operate, non-infringement, and inventorship. Leena advises clients in protecting inventions mainly in the areas of DNA, RNA, peptides, and proteins, such as antibodies and enzymes.
 
Prior to joining HGF Leena served as a VP of Intellectual Property at a global pharmaceutical company headquartered in Basel where she managed multiple patent portfolios related to drugs to be repurposed or refocused and conducted due diligence on assets under consideration to be bought or licensed. Before repatriating to Europe, she practiced patent law for almost two decades at a major law firm in the United States, where she advised clients at university technology transfer offices, start-ups and large multinational companies.
 
Before beginning her legal career, Leena conducted post-doctoral research at Harvard Medical School. Leena holds a master’s degree in biotechnology, a Ph.D. in biochemistry, and is registered to practice before the U.S. Patent and Trademark Office.  She also holds a U.S. law degree with license to practice before the courts of the Commonwealth of Massachusetts.
 
Mike Nelson, Partner at HGF commented “Leena’s appointment is an exciting development in HGF’s expansion across mainland Europe. We are delighted to welcome Leena to HGF and the experience and expertise she brings to our life science and pharmaceutical team in the Basel office.”

Advertisement

MedPharm 16/07

Advertisement

Biopharma group march 2026

Advertisement

Silgan March 2026

Advertisement

Terumo 06/26

Advertisement

Scott Pharma – 25.03.2025

Advertisement

Bespak

Advertisement

Solstice

Advertisement

Bachem skyscraper
Tjoapack
Aptar – 08/01/2026